Correlation Between Molecular Partners and ELYM Old
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and ELYM Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and ELYM Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and ELYM Old, you can compare the effects of market volatilities on Molecular Partners and ELYM Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of ELYM Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and ELYM Old.
Diversification Opportunities for Molecular Partners and ELYM Old
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Molecular and ELYM is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and ELYM Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ELYM Old and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with ELYM Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ELYM Old has no effect on the direction of Molecular Partners i.e., Molecular Partners and ELYM Old go up and down completely randomly.
Pair Corralation between Molecular Partners and ELYM Old
If you would invest (100.00) in ELYM Old on December 30, 2024 and sell it today you would earn a total of 100.00 from holding ELYM Old or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Molecular Partners AG vs. ELYM Old
Performance |
Timeline |
Molecular Partners |
ELYM Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Molecular Partners and ELYM Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Molecular Partners and ELYM Old
The main advantage of trading using opposite Molecular Partners and ELYM Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, ELYM Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ELYM Old will offset losses from the drop in ELYM Old's long position.Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |